Expression of Pax-2 in Human Renal Cell Carcinoma and Growth Inhibition by Antisense Oligonucleotides

Cancer Research

Volumn 55, Issue 18, 1995, Pages 4092-4098

  Gnarra, James R ^a   Dressier, Gregory R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE FUNCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL;

BASE SEQUENCE; CARCINOMA, RENAL CELL; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0029082823     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Oberling, C. H., Riviere, M., and Hagenau, F. R. Ultrastmcture of clear cells in renal carcinoma and its importance for the demonstration of their renal origin. Nature (Lond.), 186: 402–403, 1960.
2. Holthoefer, H., Miettenen, A., Paasivuo, R., Lehto, V. P., Under, E., Alftan, O., and Virtanen, I. Cellular origin and differentiation of renal carcinomas: a fluorescence microscopic study with kidney-specific antibodies, anti-intermediate filaments antibodies, and lectins. Lab. Invest., 49: 317–326, 1983.
3. Bander, N. H., Finstad, C. L., Cordon-cordo, C., Ramsawak, R. D., Vaughan, E. D., Jr., Whitemore, W. F., Jr., Oettgen, H. F., Melaned, M. R., and Old, L. J. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets of renal cell carcinomas. Cancer Res., 49: 6774–6780, 1989.
4. Latif, F. Kalman, T., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhousc, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chan, F., Glenn G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. -S. R., Dean, M., Glavac, D., Richards, F. R., Crossey, P. A., Ferguson-Smith, M. A., Le Paslier, D., Chumakov, I., Cohen, D., Chinault, A. C., Maher, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I. Identification of the von Hippel-lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317–1320, 1993.
5. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., Lubensky, I., Duan, D. R., Florence, C., Pozzatti, R., Walther, M. M., Bander, N. H., Grossman, H. D., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B., and Linehan, W. M. VHL tumor suppressor gene mutations in renal carcinoma tumorigenesis. Nat. Genet., 7: 85–90, 1994.
6. Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Ngashima, Y., Kitamura, H., Latif, F., Zbar, B., Lerman, M. I., and Yao, M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res., 54: 2852–2855, 1994.
7. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. -S. R., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700–9704, 1994.
8. Saxen, L. Organogenesis of the kidney. In: P. W. Barlow, P. B. Green, and C. C. White (eds.), Developmental and Cell Biology, Series 19, pp. 1–87. Cambridge, United Kingdom: Cambridge University Press, 1987.
9. Grass, P., and Walther, C. Pax in development. Cell, 69: 719–721, 1992.
10. Chalepakis, G., Stoykova, A., Wijnholds, J., Tremblay, P., and Grass, P. Pax: gene regulators in the developing nervous system. J. Neurobiol., 24: 1367–1383, 1993.
11. Dressier, G. R., and Douglass, E. C. Pax-2 is a DNA binding protein expressed in embryonic kidney and Wilms’ tumor. Proc. Natl. Acad. Sci. USA, 89: 1179–1183, 1992.
12. Dressier, G. R., Wilkinson, J. E., Rothenpieler, U. W., Patterson, L. T., Williams-Simons, L., and Westphal, H. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature (Lond.), 362: 65–67, 1993.
13. Rothenpieler, U. W., and Dressier, G. R. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development (Camb.), 119: 711–720, 1993.
14. Keller, S. A., Jones, J. M., Boyle, A., Barrow, L. L., Killen, P. D., Green, D. G., Kapousta, N. V., Hitchcock, P. F., Swank, R. T., and Meisler, M. H. Kidney and retinal defects (Krd), a transgene-induced mutation with a deletion of mouse chromosome 19 that includes the Pax2 locus. Genomics, 23: 309–320, 1994.
15. Sanyanusin, P., Schimmenti, L. A., McNoe, L. A., Ward, T. A., Pierpont, M. E. M., Sullivan, M. J., Dobyns, W. B., and Eccles, M. R. Mutation of the Pax2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat. Genet., 9: 358–364, 1995.
16. Saxen, L., Salonen, J., Ekblom, P., and Nordling, S. DNA synthesis and cell generation cycle during determination and differentiation of the metanephric mesenchyme. Dev. Biol., 98: 130–138, 1983.
17. Anglard, P., Trahan, E., Liu, S., Latif, F., Merino, M. J., Lerman, M. I., Zbar, B., and Linehan, W. M. Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res., 52: 348–356, 1992.
18. Berk, A. J., and Sharp, P. A. Spliced early mRNAs of simian virus 40. Proc. Natl. Acad. Sci. USA, 75: 1274–1278, 1978.
19. Harlow, E., and Lane, D. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
20. Eccles, M. R., Wallis, L. J., Fidler, A. E., Spurr, N. K., Goodfellow, P. J., and Reeve, A. E. Expression of the Pax2 gene in human fetal kidney and Wilms+ tumor. Cell Growth & Differ., 3: 279–289, 1992.
21. Pueschel, A. W., Westerfield, M., and Dressier, G. R. Comparative analysis of Pax-2 protein distributions during neuralation in mice and zebrafish. Mech. Dev., 38: 197–208, 1992.
22. Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., and Emanuel, B. S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumor alveolar rhabdomyosarcoma. Nat. Genet., 3: 113–117, 1993.
23. Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., III, Emanuel, B. S., Rovera, G., and Barr, F. G. Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nat. Genet., 5:230–235,1993.
24. Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G., and Rauscher, F. J., III. The Pax3-FKHR fusion protein created by te t(2;13) translocation in alveolar rhabdomyosarcoma is a more potent transcriptional activator than Pax3. Mol. Cell. Biol., 15: 1522–1535, 1995.
25. Maulbecker, C. C., and Grass, P. The oncogenic potential of Pax genes. EMBO J., 12: 2361–2367, 1993.
26. Phelps, D. E., and Dressier, G. R. Aberrant expression of Pax-2 in Danforth's short tail (Sd) mice. Dev. Biol., 157: 251–258, 1993.
27. Ryan, G., Steele-Perkins, V., Morris, J. F., Rauscher, F. J., III, and Dressier, G. R. Repression of Pax-2 by WT1 during normal kidney development. Development (Camb.), 121: 867–875, 1995.
28. Reiter, R. E., Anglard, P., Liu, S., Gnarra, J. R., and Linehan, W. M. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res., 53:3092–3097, 1993.
29. Groene, H.-J., Schwabe, G. C. Walther, C., and Grass, P. Expression of developmental control genes Pax-2 and Pax-8 in adult kidney and during regeneration of renal tubular epithelium. J. Am. Soc. Nephrol., 4: 465, 1993.
30. Neckers, L., Whitesell, L., Rosolen, A., and Geselowitz, D. A. Antisense inhibition of oncogene expression. Crit. Rev. Oncog., 3: 175–231, 1992.
31. Cang, E. H., Yu, Z., Shinozuka, K., Zon, G., Wilson, W. D., and Strekowska, A. Comparative inhibition of ras p21 protein synthesis with phosphorus-modified anti-sense oligonucleotides. Anticancer Drag Res., 4: 221–232, 1989.
32. Fickenscher, H. R., Chalepakis, G., and Grass, P. Murine Pax-2 protein is a sequence-specific fraw-activator with expression in the genital system. DNA Cell Biol., 12: 381–391, 1993.
33. Stein, C. A., and Cheng, Y.-C. Antisense oligonucleotides as therapeutic agents-is the bullet really magical? Science (Washington DC), 261: 1004–1012, 1993.